NeuroSense Therapeutics L...

NASDAQ: NRSN · Real-Time Price · USD
1.20
0.03 (2.56%)
At close: Aug 15, 2025, 3:59 PM
1.20
0.42%
After-hours: Aug 15, 2025, 06:33 PM EDT

NeuroSense Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-10.21K -10.19K -7.25K -11.62K -10.11K -9.63K -13.41K -11.67K -10.49K -9.29K -7.18K -4.63K -4.04K -5.04K -5.26K -4.64K
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.50 3.00 3.00
Stock-Based Compensation
557.00 1.54K 59.00 1.54K 1.54K 1.73K 704.00 1.73K 1.73K 3.82K 4K 3.82K 3.82K 907.00 4.44K 1.94K
Other Working Capital
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 19.50 39.00 45.00
Other Non-Cash Items
9.65K 8.65K 7.2K 10.09K 8.57K 7.9K 12.71K 9.94K 8.76K 5.47K 3.19K 814.00 223.00 3.94K 429.00 2.14K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 21.00 42.00 40.50
Operating Cash Flow
n/a n/a n/a 1.78K 1.78K 6.89K 4.08K 5.11K 5.11K n/a 2.81K n/a n/a -170 -340 -517.5
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.5 -5 -7
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.5 -5 -7
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a 3.69M 3.69M 3.69M 3.69M n/a n/a n/a n/a n/a n/a 254.00
Financial Cash Flow
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 254.00
Net Cash Flow
n/a n/a -2.33M 3.4M 1.22M 362K 2.75M -2.97M -790.19K 64.81K 2.81K n/a n/a -172.5 -345 -270.5
Free Cash Flow
n/a n/a n/a 1.78K 1.78K 6.89K 4.08K 5.11K 5.11K n/a 2.81K n/a n/a -172.5 -345 -524.5